127 related articles for article (PubMed ID: 17209523)
1. Targeted therapy for colorectal cancer.
Hwang J; Marshall JL
Curr Opin Investig Drugs; 2006 Dec; 7(12):1062-6. PubMed ID: 17209523
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms and targeting of colorectal cancer.
Vanhoefer U
Semin Oncol; 2005 Dec; 32(6 Suppl 8):7-10. PubMed ID: 16360005
[TBL] [Abstract][Full Text] [Related]
3. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma.
Venook AP
Cancer; 2005 Jun; 103(12):2435-46. PubMed ID: 15880563
[TBL] [Abstract][Full Text] [Related]
4. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived.
O'Neil BH; Goldberg RM
Expert Opin Investig Drugs; 2003 Dec; 12(12):1939-49. PubMed ID: 14640938
[TBL] [Abstract][Full Text] [Related]
5. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors].
Lang A; Graeven U
Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236
[No Abstract] [Full Text] [Related]
6. Systemic therapy for advanced or metastatic colorectal cancer: National Comprehensive Cancer Network guidelines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy.
Engstrom PF;
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):18S-22S. PubMed ID: 18980548
[TBL] [Abstract][Full Text] [Related]
7. The changing paradigm of colorectal cancer therapy: the impact of vascular endothelial growth factor and epidermal growth factor and epidermal growth factor receptor inhibition. Introduction.
Chase JL
Pharmacotherapy; 2008 Nov; 28(11 Pt 2):17S. PubMed ID: 18980547
[No Abstract] [Full Text] [Related]
8. Integrating targeted agents into therapeutic regimens for patients with resectable colorectal cancer.
Marshall JL
Clin Colorectal Cancer; 2008 Dec; 7 Suppl 2():S63-6. PubMed ID: 19064409
[TBL] [Abstract][Full Text] [Related]
9. Predicting response to epidermal growth factor receptor-targeted therapy in colorectal cancer.
Adams R; Maughan T
Expert Rev Anticancer Ther; 2007 Apr; 7(4):503-18. PubMed ID: 17428171
[TBL] [Abstract][Full Text] [Related]
10. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
11. Metastatic colorectal cancer.
Saletti P; Cavalli F
Cancer Treat Rev; 2006 Nov; 32(7):557-71. PubMed ID: 16935430
[TBL] [Abstract][Full Text] [Related]
12. Combined targeted therapies in non-small cell lung cancer: a winner strategy?
Cascone T; Gridelli C; Ciardiello F
Curr Opin Oncol; 2007 Mar; 19(2):98-102. PubMed ID: 17272980
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of signal transduction: epidermal growth factor receptor family, vascular endothelial growth factor family, Kit, platelet-derived growth factor receptor, Ras.
Erman M
J BUON; 2007 Sep; 12 Suppl 1():S83-94. PubMed ID: 17935283
[TBL] [Abstract][Full Text] [Related]
14. New agents in development for breast cancer.
Gao XP; Liu F
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):68-74. PubMed ID: 17218855
[TBL] [Abstract][Full Text] [Related]
15. Preclinical studies and clinical utilization of monoclonal antibodies in epithelial ovarian cancer.
Frederick PJ; Straughn JM; Alvarez RD; Buchsbaum DJ
Gynecol Oncol; 2009 Jun; 113(3):384-90. PubMed ID: 19232697
[TBL] [Abstract][Full Text] [Related]
16. Novel agents in the treatment of metastatic colorectal cancer.
Leong S; Messersmith WA; Tan AC; Eckhardt SG
Cancer J; 2010; 16(3):273-82. PubMed ID: 20526106
[TBL] [Abstract][Full Text] [Related]
17. Targeted agents and esophageal cancer--the next step?
Aklilu M; Ilson DH
Semin Radiat Oncol; 2007 Jan; 17(1):62-9. PubMed ID: 17185199
[TBL] [Abstract][Full Text] [Related]
18. Perspectives in colorectal cancer - Sixth Annual Conference. Metastatic colorectal cancer.
Morse MA
IDrugs; 2005 Dec; 8(12):974-7. PubMed ID: 16320126
[No Abstract] [Full Text] [Related]
19. Targeting signal transduction pathways in colorectal cancer--more than skin deep.
Cohen SJ; Cohen RB; Meropol NJ
J Clin Oncol; 2005 Aug; 23(23):5374-85. PubMed ID: 15998904
[TBL] [Abstract][Full Text] [Related]
20. Blockade of receptors for growth factors: an anticancer therapy--the fourth annual Joseph H Burchenal American Association of Cancer Research Clinical Research Award Lecture.
Mendelsohn J
Clin Cancer Res; 2000 Mar; 6(3):747-53. PubMed ID: 10741693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
